• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRI™ Website
      • ISPRI Downselect™
      • ISPRI Quantify™
      • ISPRI Analyze™
      • ISPRI Evaluate™
      • ISPRI-HCP™
      • ISPRI Design™
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAX™
      • EpiCC™
      • Ancer®
      • PreVAX™
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
  • Contact Us
Epitope-Driven TB Vaccine Development: A streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice

Epitope-Driven TB Vaccine Development: A streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice

by Adam | Oct 22, 2016

Current Molecular Medicine, Curr Mol Med. 2007 Jun;7(4):351-68.
Epitope-based vaccination against pneumonic tularemia. Vaccine. 2009

Epitope-based vaccination against pneumonic tularemia. Vaccine. 2009

by Adam | Oct 22, 2016

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone

by Adam | Oct 22, 2016

Vaccine. 2011. Jan 10;29(3):501-11. Epub 2010 Nov 4.
HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer

HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer

by Adam | Oct 22, 2016

Vaccine. 2011. Mar 3;29(11):2085-91

Recent Posts

  • Optimize Your Immunogenicity Strategy with Trusted Expert Advice 
  • EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements
  • Thinking Out Loud in February
  • Thinking Out Loud: January 2025
  • Artificial Intelligence / Human Intelligence Workshop: 2025

Recent Comments

No comments to show.

Join our newsletter

 Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot. 

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline